Purpose: To report a case of fat embolism syndrome (FES) following elective left knee arthroplasty and review the diagnosis, investigation, prevention and perioperative management of this condition.
AT embolism syndrome (FES) has been recognized since the late 1800's and extensively described following traumatic, surgical and atraumatic conditions. We present a case of FES following elective left knee arthroplasty. Previous published case reports of FES associated with elective knee arthroplasty are summarized, revealing common patterns of presentation. Recommendations for perioperative management are suggested to minimize the risk of this syndrome during knee arthroplasty.
Case report A 76-yr-old female, weighing 66 kg, with osteoarthritis of her left knee presented for left total knee arthroplasty in September 2000. Her past medical history included osteotomy of right hip, right knee arthroplasty, cholecystectomy, hysterectomy, appendectomy, bowel resection for diverticulitis, posterior fossa craniotomy for cerebello-pontine angle tumour, lower lumbar disc pathology and a hiatus hernia with reflux. She had a five-year history of stable angina. Her medication included atenolol 100 mg once daily and nitroglycerin spray as required. Preoperative echocardiography revealed mild global left ventricular dysfunction and infero-basal hypokinesis consistent with regional ischemia. A 1996 thallium scan was normal, and her electrocardiogram (ECG) revealed longstanding left bundle branch block (LBBB). Preoperative vital signs and blood tests were normal. Preoperative venous thrombo-prophylaxis with oral coumadin had been commenced.
The patient had a left total knee arthroplasty, using a thigh tourniquet, under general anesthesia. A cemented total condylar system was inserted, using femoral and tibial intramedullary alignment rods. With standard monitoring, a rapid sequence induction was carried out with fentanyl 250 µg, propofol 120 mg and suxamethonium 150 mg. Anesthesia was maintained with desflurane (end-tidal concentrations 2-3%) in nitrous oxide (70%) and oxygen. The patient was paralyzed with rocuronium, and morphine 8 mg was given intraoperatively for analgesia. Estimated intraoperative blood loss was 100 mL and the patient received 1600 mL of 0.9% saline intravenously. Vital signs were stable throughout the intraoperative course (2.5 hr). On recovery from anesthesia, the patient was awake, alert and hemodynamically stable. She required supplemental oxygen via a Venturi mask (FIO 2 0.5) to maintain oxygen saturations of 97% following a transient drop in saturations to 90% in the postanesthesia care unit on 4 L·min -1 oxygen via nasal prongs. Morphine patientcontrolled analgesia was provided. She achieved a maximal Aldrete postoperative recovery score of 10 prior to discharge to the ward.
Six hours postoperatively, she was noted to be increasingly drowsy, opening eyes to voice, withdrawing to pain but no verbal response. She was hemodynamically stable with a respiratory rate of 16·min -1 , and saturations of 97% on oxygen FIO 2 0.5. Arterial blood gases (ABG) revealed pH 7.47, pCO 2 42 mmHg, pO 2 92 mmHg, base excess -0.3, saturations 97% on 50% inspired oxygen; Hb 127 g·L -1 , WBC 16.8 × 10 9 ·L -1 , platelets 163 × 10 9 ·L -1 ; glucose 7.5 mmoL·L -1 ; Troponin C 0.6 µg·L -1 . There was no detectable metabolic derangement. Her ECG was unchanged (LBBB). The chest x-ray showed bilateral diffuse infiltrates consistent with pulmonary edema. Furosemide 40 mg iv was administered which resulted in urinary diuresis but no improvement in ABG.
With further deterioration in her neurological status 24 hr postoperatively, she was transferred to the intensive care unit. Neurological examination revealed the patient to be stuporous with no focal signs and bilateral extensor plantar responses. No retinal fat or petechiae were seen. A cerebral computed tomogram (CT) was normal. Repeat ABG on 50% oxygen had deteriorated: pH 7.46, pO 2 80 mmHg, pCO 2 36 mmHg, base excess 2.3, saturations 95%. There was no evidence of deep venous thromboses clinically or on venous ultrasounds. A lumbar puncture revealed no abnormality of cerebrospinal fluid. No other sources of sepsis were identified.
At 48 hr postoperatively, fat embolism was suspected, supported by the development of petechiae on the upper trunk and thrombocytopenia (platelets 98 × 10 9 ·L -1 ). Magnetic resonance imaging (MRI) was carried out five days postoperatively which revealed multiple small bilateral predominantly white matter changes preferentially located in the fronto-parietal "watershed" area between the major hemispheric vascular territories (Figure, 
Discussion
Fat embolism occurs in almost all lower extremity trauma and intramedullary surgery. FES, however, is a severe multisystem manifestation of embolization that occurs much less commonly. The incidence of FES in retrospective reviews is less than 1%. 1 , 2 However, there is a greater incidence reported in prospective studies of 11-29%. 3 -6 Overall mortality varies between 7-20%, 1,2 and long-term morbidity is usually due to neurological dysfunction. 7 The commonest surgical procedures predisposing to FES are intramedullary nailing of long bones, hip arthroplasty and knee arthroplasty. 7 Over the last 30 years, FES associated with knee arthroplasty has been described in at least 16 case reports. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Of these, seven proved fatal and one had poor long-term neu-rological outcome. The remaining 50% recovered completely.
Clinical presentation in these patients can be divided into two distinct groups. Eight patients presented with intraoperative cardiorespiratory collapse following femoral reaming, 1 insertion of intramedullary alignment guide 1 or cemented prosthesis, 2 or after tourniquet release. 4 Hypotension was recorded in seven to eight of these cases, with three progressing to electromechanical dissociation. Hypoxia was noted in five patients. Two patients in this group died.
Six patients presented in the postoperative period, varying from immediately postoperatively to four hours later. Only one patient had been unstable intraoperatively, with transient hypotension following tourniquet release. Postoperatively, all patients developed neurological signs, specifically disorientation or unconsciousness, and hypoxemia. In two patients this was associated with hypotension, and another developed signs of cardiac ischemia (segment depression on ECG). Three patients in this group died, and one had poor neurological recovery.
The diagnosis of FES is clinical, usually one of exclusion. Differential diagnoses of cardiorespiratory and neurological dysfunction include myocardial infarction, cardiogenic shock, infection or sepsis, pulmonary embolism, cerebrovascular accident or metabolic disturbance. In this patient with known ischemic heart disease, relative fluid overload from perioperative iv administration must also be considered.
In trauma patients, respiratory signs are seen in 75%, which may progress to respiratory failure in 10%. 7, 22 Neurological changes, seen in up to 86% of patients, may present as diffuse encephalopathy and/or with focal abnormalities. 2 3 Petechiae, which represent dermal fat embolization, are seen in 50-60% of cases usually after 24-48 hr. 2 2 They are usually distributed to the upper body-chest, neck and conjunctivae. Resolution occurs within seven days. Other non-specific symptoms, such as tachycardia, fever, retinal changes, jaundice and lipuria may also be seen. 7, 22 There are no universal criteria used for diagnosis. Those published by Gurd et al. in 1970 2 2 divided the symptoms into major and minor features for diagnosis (Table I ). These criteria have been criticized for not specifically assessing oxygenation with ABG that may be a useful early indicator of FES. 5 Schonfeld's scoring system incorporated this 6 (Table II) and Lindeque proposed respiratory parameters as alternative criteria for diagnosis of FES in trauma patients (Table III) . Our patient had clinical evidence of FES by both Gurd's and Schonfeld's criteria.
No investigation is 100% specific for the syndrome. Laboratory tests should include ABG, complete blood count to identify anemia or thrombocytopenia, and a coagulation profile to reveal bone marrow thrombo-plastin-or complement-mediated coagulopathies. 2 3 Any other treatable causes of neurological dysfunction, e.g., toxic, metabolic or infectious, must be excluded. 2 4 Urinalysis may reveal fat globules but this is non-specific. The ECG may be normal, reflect right heart strain or may reveal ischemia. 7 The chest radiograph is non-specific, with diffuse fluffy bilateral infiltrates and opacities consistent with increased capillary permeability and edema. 7 MRI has been shown to be more sensitive than CT in the identification of cerebral FES, with the abnormalities typically appearing as hyperintense lesions on T2-weighted, proton density and FLAIR sequences, characteristically located along the boundary zones of the major vascular territories, 2 5 as was the case in our patient. This "watershed" distribution of the MRI abnormalities presumably represents a tendency for the embolic particles to lodge in the small terminal branches of the major hemispheric vessels.
Identification of at risk patients preoperatively is important. Medically, those with pre-existing cardiac or respiratory disease have decreased physiological reserve, and are at greater risk of cardiorespiratory collapse following an embolic load. Patients with metastatic disease, myeloblastic disorders, rheumatoid arthritis, collagen vascular disease or osteopenia are at risk due to enlargement and increased liquid marrow content of the medullary canals. 1 9 The risk may be increased in bilateral surgical procedures, presumably due to increased embolic load. A patent foramen ovale, present in up to 34% of people, 2 6 provides a means of paradoxical fat embolization in the event of pulmonary hypertension and increased right atrial pressure.
Intraoperatively, in addition to standard monitoring in high-risk patients or procedures, use of an arterial line for continuous hemodynamic and blood gas monitoring is recommended. 2 1 Intraoperative transesophageal echocardiography may detect fat embolization and monitor intraoperative volume status and cardiac function. 2 1 Pulmonary artery pressure monitoring has also been recommended, both as a diagnostic and prognostic tool, in bilateral procedures. 2 1 Although more invasive monitoring improves detection of embolization and its sequelae, there is no evidence to suggest these interventions improve outcome in FES.
Close postoperative monitoring should identify early signs of respiratory deterioration, using routine pulse oximetry, regular blood gas analysis and supplemental oxygen. 2 1 Modification of surgical technique may lessen the risk. Increased intramedullary pressure has been implicated as the source of fat emboli due to fat intravasation from the bone marrow cavity. 7 The shift towards the use of total condylar components from long-stemmed prostheses obviates the need for extensive intramedullary manipulation. However, intramedullary alignment guides have also been implicated. 1 8 Venting of the femoral shaft and lavage of the medullary canal minimizes increases in intramedullary pressure and the amount of fatty bone marrow present. 2 1 Methylmethacrylate cement insertion results in pressurization of the intramedullary fat and direct vasodilatation leading to transient hypotension. 2 7 The presence of a tourniquet does not prevent embolization and FES but may modulate the time course of events and limits the vasodilatory consequences of the cement insertion. To prevent hypoxemia intraoperatively, 100% oxygen administration during cementing and prosthesis insertion in patients at risk has been recommended anecdotally although there are no prospective studies confirming this. 2 1 Fluid therapy to prevent hypovolemia is also important, as canine studies have shown that acute hemodynamic changes during prosthesis insertion and fat embolism may increase in hypovolemic states. 2 7 Recent reports of intraoperative cardiac instability due to fat embolization have recommended maintenance of perfusion pressure with vasoconstrictors to preserve right heart perfusion and function. 2 3 Treatment is essentially supportive, consisting of cardiovascular and respiratory resuscitation and stabilization. No specific drug therapy for FES is currently recommended. Small prospective randomized controlled studies of steroid prophylaxis in patients with long bone fractures have indicated both a decrease in development of FES and a decreased incidence of hypoxemia in steroid treated groups compared to controls. However, dose regimens were not standardized, varying from 1.5 mg·kg -1 methylprednisolone 8 hourly to 30 mg·kg -1 4 hourly. 4 , 5 In a canine model of cemented arthroplasties, Byrick et al. demonstrated no attenuation of hemodynamic or prostanoid response in acute lung injury following treatment with methylprednisolone 30 mg·kg -1 iv 20 min prior to reaming. 2 8 Other drugs, such as heparin, iv alcohol, dextrans and hypertonic dextrose, have not proved to be of any benefit and may be detrimental. 21 In summary FES is a significant cause of mortality and morbidity not only in trauma patients but increasingly recognized in association with elective orthopedic surgery. Two main presentations are seen in knee arthroplasties: intraoperative cardiorespiratory collapse, or postoperative respiratory and cerebral dysfunction. A high index of suspicion is required for early clinical diagnosis in at-risk patients.
